In a world-first clinical trial, lab-grown red blood cells have been transfused into humans. If successful, its continuation will bolster supplies for those with rare blood types and improve treatment for people who require regular transfusions.
You’ve heard of lab-grown meat, but what about lab-grown human blood?
For the very first time, a couple of spoonfuls (5-10ml) of lab-grown blood have been injected into volunteers participating in the RESTORE randomised controlled clinical trial in the UK.
These trials, if successful, would help to meet blood supplies for people with unique blood types. Professors at the University of Bristol said certain blood groups are so rare that they can only find matches in 10 people across the UK.
Looking to the future, lab-manufactured blood cells could revolutionise treatment for patients with rare blood types and conditions such as sickle cell and thalassemia.
Those living with these diseases rely on donated blood for regular transfusions, which can become more complex to accomplish over time.
Scientists started manufacturing lab-grown red blood cells using stem cells from human blood donors.
They have anticipated that cells grown in the lab will outperform standard donated blood, as the lab-grown cells are far fresher. If correct, this would mean that patients regularly receiving blood transfusions won’t need to get them as often.
Better performing lab-grown cells would also mean fewer transfusions needed per patient. This would lower the risk of patients experiencing iron overload, a complication sometimes seen in people receiving regular blood transfusions.
Dr Farrukh Shah, Medical Director of Transfusion for NHS Blood and Transplant, said:
‘Patients who need regular or intermittent blood transfusions may develop antibodies against minor blood groups. [This] makes it harder to find donor blood which can be transfused without the risk of a potentially life-threatening reaction.’
Monitoring the results
The NIHR Cambridge Clinical Research Facility is overseeing the clinical trial, having recruited two healthy volunteers.
So far, the two volunteers are healthy and well, showing no side effects. In the coming months, a minimum of ten more volunteers are expected to receive two mini-transfusions – both lab-grown and traditional – at least four months apart.
The goal of this dual trial is to compare the lifespan of the two types of blood donations in the body, to see whether lab-grown blood is longer-lasting in its positive effects.
Hopefully, the success of the trial will advance the mission to make lab-grown red blood cells more widely available for people who need it.
Professor Lucy Chappell, Chief Executive of the NIHR said:
‘These NIHR-supported researchers have made it possible to grow blood in the lab, turning what sounds like science fiction into a ground-breaking reality… This is really exciting progress that is another example of the world-leading life sciences opportunities that the UK has to offer.’
Fingers crossed the trial goes well, as over 2.5 million units of blood are transfused into UK patients by the NHS every year!
Deputy Editor & Content Partnership ManagerLondon, UK
I’m Jessica (She/Her). I’m the Deputy Editor & Content Partnership Manager at Thred. Originally from the island of Bermuda, I specialise in writing about ocean health and marine conservation, but you can also find me delving into pop culture, health and wellness, plus sustainability in the beauty and fashion industries. Follow me on Twitter, LinkedIn and drop me some ideas/feedback via email.
A regional war that first threatened oil supplies is now threatening the lifeline of the healthcare industry: medicines.
The closure of the Strait of Hormuz is widely framed as an energy crisis, but its consequences extend far beyond oil. Beneath the headlines a larger, potentially more dangerous disruption is unfolding, and that is a global healthcare emergency driven by the breakdown of pharmaceutical supply chains.
At the center of this...
With irregular migration rates on the rise, the new deal involves aggressive physical intervention and conditional pay to prevent the influx of migrants afflicting the UK.
Though it peaked in 2015, the European migration crisis continues to dominate many parliamentary discussions to this day. With millions being displaced by conflicts in their home countries, they have nowhere to turn to but Europe.
For these migrants, the first point of arrival...
Ticket prices for the tournament final have reached the tens-of-thousands, and fans have been left clamouring for overpriced, poorly positioned seats. As FIFA squeezes out every dollar, does the organisation risk alienating a dedicated fanbase?
Football is a global phenomenon. And for all the team rivalry, it’s a sport that generally brings people together from across the globe. Never more so than during the World Cup, the largest tournament in...
For communities living through ongoing conflict, mental health is not a separate crisis. It is built into the conditions of everyday life.
At present, there are 61 active conflicts happening across the globe.
So, let’s not dress this up in a polite way: communities grappling with constant wars and hostilities aren't just struggling when it comes to mental health, they are in the midst of a full-fledged psychological crisis.
In...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
0 comments
